Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
11/2004
11/11/2004WO2004065422A3 Cancerous disease modifying antibodies
11/11/2004WO2004064750A3 Improved constructs for expressing lysosomal polypeptides
11/11/2004WO2004038367A3 Biological assays using gradients formed in microfluidic systems
11/11/2004WO2004015070A3 Isolation and identification of t cells
11/11/2004WO2004010933A3 Insulin-producing cell compositions and related methods
11/11/2004WO2004009799A3 Ion channel receptor and uses thereof
11/11/2004WO2003102166A8 Novel flavivirus antigens
11/11/2004WO2003101394A3 Defensins: use as antiviral agents
11/11/2004WO2003071859A3 Methods for increasing the amount of protein in potato tubers
11/11/2004WO2003070747A3 Insulin and igf-1 receptor agonists and antagonists
11/11/2004WO2003060150A8 Nucleic acids encoding a g-protein coupled receptor involved in islet cell signaling
11/11/2004WO2003059264A9 Methods for the induction of professional and cytokine-producing regulatory cells
11/11/2004WO2003051285A3 Therapeutic anti-hiv (iv9) compounds
11/11/2004WO2003038052A3 Nucleic acid-associated proteins
11/11/2004WO2003027239A3 Melanin-concentrating hormone receptor antagonist binding protein
11/11/2004WO2003012068A3 Novel fusion proteins and assays for molecular binding
11/11/2004WO2003012044A3 Hagfish cathelin-associated antimicrobial peptides and genes
11/11/2004US20040226058 Prolonged culturing of avian (chicken) primordial germ cells (PGCs) using specific growth factors, use thereof to produce chimeric avians (chickens)
11/11/2004US20040225374 Incubation osteogenic cell with animal growth regulator; culturing; screening for bone cell spheroids
11/11/2004US20040225118 31 human secreted proteins
11/11/2004US20040224911 Transporters and ion channels
11/11/2004US20040224910 Recombinant nematode nicotinic receptor and uses
11/11/2004US20040224888 Use of cardiotrophin in liver diseases
11/11/2004US20040224887 Systems and methods for screening for modulators of neural differentiation
11/11/2004US20040224882 modulating cell growth, cell differentiation, or cell survival; genetic engineering using hedgehog genes and proteins; neurodegenerative diseases; tissue-targeted therapy
11/11/2004US20040224878 Fertilization of aged oocytes
11/11/2004US20040224424 Nucleotide sequences comprising allelic variant of cytochrome p450 for use in diagnosis and treatment of cell proliferative, nervous system and cardiovascular disorders; pharmacodynamic profiles and drug screening
11/11/2004US20040224411 Transgenic cell comprising adenoviral vector for use as gene delivery tool; tissue engineering heterologous gene expression; DNA vaccines
11/11/2004US20040224407 Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
11/11/2004US20040224406 Nonimmunogenic, biodegradable, growth promoting yarn comprising fibroin fibers for use in hernia repair, tissue wall reconstruction, drug delivery and organ support; biological scaffolds
11/11/2004US20040224405 Using RNA interference to control gene expression in cells; antisense agents and genetic suppressor elements; tissue targeted therapy and engineering
11/11/2004US20040224404 Conditionally replicating viral vectors and their use
11/11/2004US20040224403 Reconstituting hematopoietic cell function using human embryonic stem cells
11/11/2004US20040224402 Generation and isolation of antigen-specific T cells
11/11/2004US20040224401 Physiochemical culture conditions for embryonic stem cells
11/11/2004US20040224386 Protein tyrosine kinases
11/11/2004US20040224385 Zinc finger binding domains for cnn
11/11/2004US20040224356 Novel human enzymes of the metalloprotease family
11/11/2004US20040224323 PAK5 screening methods
11/11/2004US20040224314 G-protein coupled receptors
11/11/2004US20040224313 Comprises nucleotide sequences coding cytochrome p450 oxygenase variant for identifying modulator use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; antitumor agents
11/11/2004US20040224302 An in vitro system containing embryonic stem cells, a rostralizing or caudalizing embryonic signalling factor, and a dorsalizing or ventralizing embryonic signalling factor; drug screening
11/11/2004US20040224300 Method for separating nucleated cells
11/11/2004US20040224009 Devices comprising artificial antigen-presenting cellls
11/11/2004US20040224002 Artificial synapse chip
11/11/2004US20040223968 inhibiting a condition characterized by monocytic infiltrates such as atherosclerosis by administering an MCP-1 receptor antagonist that binds to an MCP-1 receptor polypeptide, especially a humanized or monoclonal antibody.
11/11/2004US20040223965 Hepatitis b core antigen fusion proteins
11/11/2004US20040223964 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/11/2004US20040223952 Generation and/or reduction of new lung tissue in an affected lung
11/11/2004DE10317402A1 Ex-vivo-Hautorganmodell, insbesondere für männliche Haut Ex vivo skin organ model, especially for male skin
11/11/2004CA2565581A1 Apparatus and methods for amplification of blood stem cell numbers
11/11/2004CA2524360A1 Novel composition and methods for the treatment of immune disorders
11/11/2004CA2523792A1 Process for the production of biological substances by perfusion culturing of suspended animal cells
11/11/2004CA2523537A1 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
11/11/2004CA2523517A1 Bcl2l12 polypeptide activators and inhibitors
11/11/2004CA2523323A1 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype
11/11/2004CA2523025A1 Spex compositions and methods of use
11/11/2004CA2522925A1 Transgenic expression of a phytochrome a gene
11/11/2004CA2522779A1 Inducers of recombinant protein expression
11/11/2004CA2522154A1 Recombinant plant dicer
11/11/2004CA2519241A1 Compositions and methods for the diagnosis and treatment of tumor
11/10/2004EP1475436A1 Swine rag-1 gene and utilization thereof
11/10/2004EP1475434A1 Method for storing tumor cells
11/10/2004EP1475433A1 Transfection method for mammalian cells
11/10/2004EP1474687A2 Marks as modifiers of the p53 pathway and methods of use
11/10/2004EP1474686A1 Method for generating recombinant human platelets for identifying therapeutic target proteins
11/10/2004EP1474682A2 Production of human antibodies in immunodeficient, non-human, mammalian hosts
11/10/2004EP1474535A2 Methods and compositions for treating aids and hiv-related disorders using 1414, 1481, 1553, 34021, 1720, 1683, 1552, 1682, 1675, 12825, 9952, 5816, 10002, 1611, 1371, 14324, 126, 270, 312, 167, 326, 18926, 6747, 1793, 1784, or 2045 molecules.
11/10/2004EP1474528A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/10/2004EP1474526A2 Enzyme activation protease assay
11/10/2004EP1474516A2 Methods of modulating cold sensory perception
11/10/2004EP1474512A2 Method to modify differentiation of pluripotential stem cells
11/10/2004EP1474508A2 Phytase variants
11/10/2004EP1474505A1 Vaccination and vaccine and drug delivery by topical application of vectors and vector extracts recombinant vectors, and noninvasive genetic immunization, expression products therefrom,and uses thereof
11/10/2004EP1474448A1 Rrp sequences and knockout mice and uses thereof
11/10/2004EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004EP1474442A2 Cytotoxic t-cell epitopes from chlamydia
11/10/2004EP1474434A2 The eaat2 promoter and uses thereof
11/10/2004EP1474167A2 Novel proteins in enteroaggregative esheriachia coli (eaec) useful for diagnosis and therapy of eaec infections
11/10/2004EP1474156A2 Materials from bone marrow stromal cells for use in forming blood vessels and producing angiogenic and trophic factors
11/10/2004EP1425045A4 Adenoviral vector and related system and methods of making and use
11/10/2004EP1297119B1 Method for introducing nucleic acids and other biologically active molecules into the nucleus of higher eukaryotic cells by means of an electrical current
11/10/2004EP1267897B1 Treatment of congestive heart failure by pretreated autologous blood
11/10/2004EP1248833A4 Therapeutic agent for ischemia which inhibits apoptosis under ischemic condition
11/10/2004EP1166112A4 Method for quantifying transforming growth factor-beta 1 and method for detecting cancer by using same
11/10/2004EP1137767B1 Vectors having terminal repeat sequence of epstein-barr virus
11/10/2004EP1003366A4 Methods for producing sialyloligosaccharides in a dairy source
11/10/2004EP0658206B1 Inhibitor resistant serine proteases
11/10/2004CN1545621A Method for selecting antibody expressing cells
11/10/2004CN1545554A Modification of plant genomes
11/10/2004CN1545553A Method for producing recombinant trypsin
11/10/2004CN1545552A Genes and proteins, and their uses
11/10/2004CN1545551A Human monoclonal antibody against hepatitis C virus E2 glycoprotein
11/10/2004CN1545550A Production of infectious hepadnavirus particles containing foamy retrovirus envelope proteins and methods of using the same
11/10/2004CN1545549A Isolation of inner cell mass for the establishment of human embryonic stem cell (hESC) lines
11/10/2004CN1545548A Carbon monoxide improves outcomes in tissue and organ transplants and suppresses apoptosis
11/10/2004CN1545526A Coating material for leukocyte removal filter and the filter material
11/10/2004CN1545416A Method of curing injured spinal cord and therapeutic agents for that
11/10/2004CN1544641A Method for improving plant nutrition quality utilizing gene engineering technology
11/10/2004CN1544632A Gene associated with plant salt resistance and drought resistance, encoded protein and application thereof